Cinclus Pharma
SwedenEntry
2022
Hold
2yr
Exit
2024
Who owns Cinclus Pharma?
Cinclus Pharma was owned by Trill Impact through Trill Impact Ventures (2021 vintage) from 2022 to 2024, exited via IPO. Across its history, Cinclus Pharma has been through 2 private equity ownership periods, detailed in the timeline below.
Hand-verified · updated 2026-07-17
Most recent investor
Trill ImpactTrill Impact Ventures · 2021 · VC
3 ownership periods · full history below
Key facts
Key takeaways
- ·Fully exited in 2024.
- ·Average hold across 2 realized cycles: 2 years.
Ownership history
2 ownership periods · co-invest detected · 1 lender on file
Exited
Last exited in 2024.
Co-invest · 2 holders · 2022 · 2024
Claret Capital PartnersLender
2026 · present(<1yr) · Claret European Growth Capital Fund IV · 2025 · Private Debt
More from Trill Impact Ventures
Other portfolio companies in the same fund.
Germany
France
Belgium
UK
DenmarkMore PE-backed in Pharma
Comparable pharma deals from other GPs.
US
Track Cinclus Pharma
Save this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Cinclus Pharma?
7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Cinclus Pharma.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue